The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...
What exactly is optimal medical therapy (OMT) for angina relief? And how long should doctors prescribe it before proceeding to an invasive approach in symptomatic patients with stable ischemic heart ...
A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...
Health on MSN
Everything To Know About Stable Angina
Stable angina causes chest pain during physical activity or stress, and it often resolves with rest or medication. You can ...
Coronary heart disease and cerebrovascular disease continue to be the leading causes of illness and death in adults from developed countries. High blood pressure is the most prevalent cardiovascular ...
BOSTON, Nov. 12, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing innovative therapies designed to improve patient symptoms and ...
Professor, Michigan State University, East Lansing, Mich. We have reported multiple studies for approximately 20 years that have shown that mortality and cardiac events are comparable for patients ...
Stents are like scaffolding that keep narrowed arteries open. These devices have been revolutionary in treating heart attacks, where their use has increased year on year, and countless lives have been ...
Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.
The results of this large, open-label, daily-practice study suggest that 8-week treatment with the metabolic anti-ischaemic agent trimetazidine MR at a dose of 70mg daily leads to an improvement in ...
Calgary, Alberta--(Newsfile Corp. - September 16, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ ...
When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results